Author

Matthew Paul Padula

University of Technology SydneyORCID 0000-0002-8283-0643Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Assay:proteomics· 2 Organism:bacteria (other)· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Abderrahman HachaniiD· 1 shared Éric DézieliD· 1 shared Georgios PappasiD· 1 shared Marie‐Christine GroleauiD· 1 shared Matthias ManniD· 1 shared Pauline M. L. CouloniD· 1 shared Sonja KabatnikiD· 1 shared Sophia SteigerwaldiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Abderrahman HachaniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Quorum sensing and DNA methylation play active roles in clinical Burkholderia phase variation

Pauline M. L. Coulon, Marie‐Christine Groleau, Abderrahman Hachani, Matthew Paul Padula, Timothy P. Stinear, Éric Déziel

This study identifies quorum sensing and adenosine DNA methylation as two antagonistic systems controlling phase variation in Burkholderia ambifaria clinical isolates.

Journal of Bacteriology · Feb 14, 2025Peer-reviewedMicrobiology

Deep Visual Proteomics reveals DNA replication stress as a hallmark of Signet Ring Cell Carcinoma

Sonja Kabatnik, Xiang Zheng, Georgios Pappas, Sophia Steigerwald, Matthew Paul Padula, Matthias Mann

This study uses Deep Visual Proteomics to analyze SRCC proteomics, identifying DNA replication stress and immune-related features, suggesting pembrolizumab may be more effective than chemotherapy.

npj Precision Oncology · Feb 5, 2025Peer-reviewedCancer Biology